Literature DB >> 28404554

Oesophageal eosinophilia in children with coeliac disease.

Anne Ari1,2, Sara Morgenstern3,4, Gabriel Chodick4, Manar Matar1, Ari Silbermintz1, Amit Assa1,4, Yael Mozer-Glassberg1,4, Firas Rinawi1, Vered Nachmias-Friedler1, Raanan Shamir1,4, Noam Zevit1,4.   

Abstract

OBJECTIVES: An association between coeliac disease (CD) and eosinophilic oesophagitis (EoE)/oesophageal eosinophilia (EE) has been suggested. We sought to characterise children with CD+EE in-depth and assess the contribution of each condition to the clinical presentation and treatment response. STUDY
DESIGN: Medical records of children with both CD+EE, or isolated EoE diagnosed between 2000 and 2014, were retrospectively reviewed and compared with patients with isolated CD or epigastric pain. Frequency of EE was calculated from endoscopy results of patients with suspected CD or epigastric pain between 2011 and 2014. Missing data were obtained via a telephone questionnaire.
SETTING: Single large, tertiary paediatric centre. PATIENTS: 17 CD+EE, 46 EoE, 302 isolated CD and 247 epigastric pain.
RESULTS: The patients with CD+EE shared characteristics of both individual conditions. While age at diagnosis, family history of autoimmunity/CD and anaemia were similar to patients with CD, other characteristics such as male gender, personal/family history of atopy, peripheral eosinophilia and oesophageal white papules were more similar to patients with EoE. Combined patients (CD+EE) tended to present with CD-associated symptoms; the majority (63%) later developed typical EoE symptoms. Only a minority (21%) of combined patients had EE that resolved after a gluten-free diet; another 21% had normalisation of EE upon proton pump inhibitor treatment. The remainder required EoE-specific treatment.
CONCLUSION: Patients with CD found to have EE share characteristics with both isolated CD and EoE. It appears that these are two coexisting entities presenting in the same patient rather than eosinophilia associated with CD, and therefore, interventions separately addressing each condition may be considered. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Coeliac disease; Eosinophilic oesophagitis; celiac disease; eosinophilic esophagitis; esophageal eosinophilia

Mesh:

Year:  2017        PMID: 28404554     DOI: 10.1136/archdischild-2016-311944

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  6 in total

Review 1.  A Comprehensive Review of Celiac Disease/Gluten-Sensitive Enteropathies.

Authors:  Brian P McAllister; Emmanuelle Williams; Kofi Clarke
Journal:  Clin Rev Allergy Immunol       Date:  2019-10       Impact factor: 8.667

2.  Eosinophilic oesophagitis and coeliac disease: is there an association?

Authors:  Ana Margarida Vaz; Antonio Jesus Cadilla; Diamantino Sousa; Horácio Guerreiro
Journal:  BMJ Case Rep       Date:  2017-11-09

3.  Screening children for eosinophilic esophagitis: allergic and other risk factors.

Authors:  Melanie A Ruffner; Peter Capucilli; David A Hill; Jonathan M Spergel
Journal:  Expert Rev Clin Immunol       Date:  2019-02-20       Impact factor: 4.473

4.  Esophageal Eosinophilia and Eosinophilic Esophagitis in Celiac Children: A Ten Year Prospective Observational Study.

Authors:  Fernanda Cristofori; Fulvio Salvatore D'Abramo; Vincenzo Rutigliano; Vanessa Nadia Dargenio; Stefania Castellaneta; Domenico Piscitelli; Davide De Benedittis; Flavia Indrio; Lidia Celeste Raguseo; Michele Barone; Ruggiero Francavilla
Journal:  Nutrients       Date:  2021-10-24       Impact factor: 5.717

Review 5.  Eosinophilic esophagitis-established facts and new horizons.

Authors:  Luc Biedermann; Alex Straumann; Thomas Greuter; Philipp Schreiner
Journal:  Semin Immunopathol       Date:  2021-06-07       Impact factor: 9.623

6.  Gastrointestinal Eosinophil Responses in a Longitudinal, Randomized Trial of Peanut Oral Immunotherapy.

Authors:  Benjamin L Wright; Nielsen Q Fernandez-Becker; Neeraja Kambham; Natasha Purington; Shu Cao; Dana Tupa; Wenming Zhang; Sayantani B Sindher; Matthew A Rank; Hirohito Kita; David A Katzka; Kelly P Shim; Bryan J Bunning; Alfred D Doyle; Elizabeth A Jacobsen; Mindy Tsai; Scott D Boyd; Monali Manohar; R Sharon Chinthrajah
Journal:  Clin Gastroenterol Hepatol       Date:  2020-05-17       Impact factor: 13.576

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.